Affera’s technology for cardiac arrhythmia treatment to be highlighted
Affera, a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today its integrated platform…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 May 19
Affera, a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today its integrated platform…
06 May 19
Enzymatica has now finalized the enrolment to its prospective double-blind, placebo-controlled multicentre study to evaluate the effects of…
02 May 19
South Africans are making strides in the scientific and healthcare fields as medical companies in South Africa are…
Patient Care DevicesPatient Care MonitoringDiagnostic Devices
29 Apr 19
Xvivo Perfusion has secured approval from the US Food and Drug Administration (FDA) for its new device, which…
26 Apr 19
The US is facing its biggest measles outbreak in almost 20 years due to millions of children being…
02 Apr 19
Royal Philips, a health technology provider, has launched the new over-the-nose nasal mask DreamWisp, which allows sleep apnea…
01 Apr 19
Olympus Medical Systems has announced that a patient with severe emphysema has been treated using endobronchial valve treatment…
27 Mar 19
Third Pole Therapeutics, a privately held company developing and delivering transformative cardio-pulmonary therapies, has entered into a strategic…
25 Mar 19
Equivital has developed a healthcare wearable for the US military that can withstand environmental pressures to collect physiological…
13 Mar 19
El Camino Hospital today announced it is the first hospital in California to have successfully performed the new…